Use of Track Health Function of the MyHealthevet Personal Health Record

Status Completed

Clinical Trial Summary

This study was a pilot 3-month clinical trial that investigated the feasibility, effectiveness, and acceptability of using the Track Health function of the Veterans Health Administration's patient health record for effecting a more positive physical activity (PA) and dietary intake lifestyle in a sample of 38 overweight and obese Veterans with prediabetes. Baseline and three-month post-intervention outcomes were measured in two main domains: objective (e.g., weight) and subjective (e.g., self-efficacy).

Clinical Trial Description

This was a pilot clinical trial that used a single-group design to test the feasibility, effectiveness, and acceptability of using the Track Health (TH) function of My HealtheVet, the VA's patient health record (PHR), as a tool for effecting a more positive physical activity (PA) and dietary intake lifestyle in overweight and obese Veterans with prediabetes. Baseline and three-month post-intervention outcomes were measured in two main domains: objective (PA as measured by an accelerometer, diet, weight, abdominal circumference, BMI, and blood pressure) and subjective (self-efficacy, intent to adhere to lifestyle change, and patient activation). Assessments, including screening on inclusion and exclusion criteria, physiological measurements, administration of questionnaires, and training on use of two critical features of the TH function--the use of Journals to enter dietary and PA data and the use of Vitals + Readings to enter weight and track physiological measures--took place place across four visits to the study site, which was the Veterans Administration Medical Center in Miami. The investigators hypothesized that this PHR-based intervention would demonstrate improvements and increases, respectively in the objective and subjective domain measures. The investigators also hypothesized that engagement by study participants with MHV would be demonstrated through meeting target criteria regarding making entries into this PHR's TH function, and that participants would be satisfied with the intervention. ;

Study Design

Related Conditions & MeSH terms

Prediabetic State

Clinical Trial Details

NCT number	NCT02921425
Study type	Interventional
Source	VA Office of Research and Development
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2014
Completion date	September 30, 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05424107` - A Mediterranean Intervention on Prediabetic Children	N/A
Recruiting	`NCT02681887` - Effect of Melatonin on Cardiometabolic Risk- FULL	Phase 3
Completed	`NCT04088461` - Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine	Phase 4
Recruiting	`NCT02561377` - Effect of Resistance Training on Metabolic Control and Outcome in Prediabetes (NMR-based Metabonomics)	N/A
Completed	`NCT02678390` - Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes	N/A
Completed	`NCT02551640` - Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients	N/A
Completed	`NCT02459691` - Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos)	N/A
Completed	`NCT01479933` - Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes	N/A
Completed	`NCT01671293` - Multicomponent Telecare Model for Supporting Prediabetes Patients	N/A
Completed	`NCT00960973` - The Effect of Vitamin K Supplementation on Glucose Metabolism	Phase 4
Completed	`NCT00455325` - Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)	Phase 2
Recruiting	`NCT05123963` - Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors	N/A
Recruiting	`NCT05340868` - Genetics of the Acute Response to Oral Semaglutide	N/A
Recruiting	`NCT04984421` - IMplementation of the Family Support PRogramme A Healthy School Start to Prevent OVErweight and Obesity (IMPROVE)	N/A
Recruiting	`NCT04134650` - Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes	Phase 3
Recruiting	`NCT04131582` - Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes	Phase 3
Recruiting	`NCT05347030` - Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population	N/A
Completed	`NCT04074148` - Effectiveness of Diabetes Prevention Education Program on Diabetes Prevention Among Prediabetes Population in Nepal	N/A
Recruiting	`NCT05050266` - Enhancing Mental and Physical Health of Women Veterans	N/A
Completed	`NCT02684565` - Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.